Eun Jeong Cho received her B.S. and M.S. in chemistry and inorganic chemistry from Yonsei University, Department of Chemistry in Seoul, South Korea in 1889 and 1991, respectively. Before moving to the United States, she worked for the Korea Institute for Science and Technology (KIST) for six years as a research scientist. She earned her Ph.D. in analytical chemistry from SUNY Buffalo in 2002 and was a postdoctoral fellow at The University of Texas at Austin (UT) for four years before becoming the first core facility director of the UT Drug Discovery Program. Since 2006, she has led the UT Small Molecule Screening Core Facility, which was renamed as The UT Targeted Therapeutic (TTP) Drug Discovery Program, with the funding from Cancer Prevention and Research Institute of Texas (CPRIT).
Her current research interests are design and development of biochemical and cellular assays for high-throughput small molecule screening against various cancer targets including breast, prostate, lung, brain and others. She also is studying on the mechanism of action of novel anticancer agents and the signal transduction cascades of protein kinases. Cho has published more than 40 scientific articles and holds six U.S.-issued patents.
SLAS publishes two MEDLINE-indexed journals and accepts manuscripts on an ongoing basis from members and non-members. > READ MORE
December 22, 2017